Horizon Pharma ACTIMMUNE® (interferon gamma-1b) Phase 3 failed

General
1

Horizon Pharma plc Announces Topline Results from Phase 3 Study of ACTIMMUNE® (interferon gamma-1b) in Friedreich’s Ataxia

I had so many hopes on this …

http://ir.horizon-pharma.com/releasedetail.cfm?ReleaseID=1003338

2

I’m sad to hear this @sunny8088, but, keep your head up!

3

Thanks there is nothing in short future